Remeron (mirtazapine) is a tetracyclical antidepressant. It increases noradrenalin and serotonin levels in cerebrum alleviating depression.
Studies show that during the first 6 weeks of therapy 37 patients out of 50 had positive effects. The rest of the patients did not have significant improvements. It was discovered that Remeron is effective in treating classic depression along with aggravated forms of depression such as despair, gloom, sleeping and appetite disorders, pessimistic mood, frustration and overall deferred reactions.
Mirtazapine is effective in treating anxious depression with the following symptoms:
- Severe discomfort
- Psychological and physical tension
- Somatic-vegetative disorders
Remeron was found to be well carried by patients, does not induce suicide thoughts and almost does not have side effects.
- Different stages of depression
- Posttraumatic stress
- Hyper sensitivity to mirtazipin and other ingridients
- Kidneys and liver disorders
- Do not take mirtazipin together with monoamine oxidase inhibitors (take 2 weeks break after the last MAO inhibitor was taken before using mirtazipin).
Adults: minimum daily dosage is 15mg. If necessary the dosage may be gradually increased (every two days). Average effective dosage is 15-45 mg in 24 hours. In some cases, the dosage may be increased up to 60-80mg per 24 hours.
Elderly adults: the dosage should not be decreased, however if any reactions occur, seek medical advise.
The course of treatment is 4-6 months. The drug activates on the second week of usage. If the effect has not occurred, the dosage may be increased. If after an extended time there is no effect, the drug should be canceled.
- Increased appetite
- Dry mouth
Remeron is a tetracyclical antidepressant with a sedative effect. The medication has anxiolytic properties.